Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Gains from Investment Securities (2016 - 2025)

AtriCure (ATRC) has disclosed Gains from Investment Securities for 15 consecutive years, with $357000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $357000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $18.3 million, a N/A change, with the full-year FY2024 number at $619000.0, changed N/A from a year prior.
  • Gains from Investment Securities was $357000.0 for Q3 2025 at AtriCure, down from $5.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $184.8 million in Q3 2021 to a low of -$10.7 million in Q2 2022.
  • A 4-year average of $20.3 million and a median of $1.4 million in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 7912.5% in 2021, then plummeted 317.71% in 2022.
  • AtriCure's Gains from Investment Securities stood at $111000.0 in 2021, then plummeted by 41.44% to $65000.0 in 2022, then surged by 8729.23% to $5.7 million in 2023, then plummeted by 93.78% to $357000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Gains from Investment Securities are $357000.0 (Q3 2025), $5.7 million (Q1 2023), and $65000.0 (Q4 2022).